Literature DB >> 14908854

Some pharmacodynamic effects of 1-hydrazinophthalazine (C-5968) with particular reference to renal function and cardiovascular response.

J H MOYER, C A HANDLEY, R A HUGGINS.   

Abstract

Entities:  

Keywords:  CARDIOVASCULAR SYSTEM/effect of drugs on; HYDRAZINE; KIDNEYS/blood supply

Mesh:

Substances:

Year:  1951        PMID: 14908854

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  11 in total

1.  EFFECT OF DOPAMINE IN MAN: AUGMENTATION OF SODIUM EXCRETION, GLOMERULAR FILTRATION RATE, AND RENAL PLASMA FLOW.

Authors:  R H MCDONALD; L I GOLDBERG; J L MCNAY; E P TUTTLE
Journal:  J Clin Invest       Date:  1964-06       Impact factor: 14.808

2.  METHYLDOPA IN TREATMENT OF HYPERTENSION DUE TO CHRONIC RENAL DISEASE.

Authors:  R G LUKE; A C KENNEDY
Journal:  Br Med J       Date:  1964-01-04

3.  The effects of 1-hydrazinophthalazine upon coronary hemodynamics and myocardial oxygen metabolism in essential hypertension.

Authors:  G G ROWE; J H HUSTON; G M MAXWELL; A B WEINSTEIN; H TUCHMAN; C W CRUMPTON
Journal:  J Clin Invest       Date:  1955-05       Impact factor: 14.808

4.  [Effect of peroral prolonged therapy with 1,4-dihydrazinophthalazine on circulation and reflex changes in dogs].

Authors:  V EHRLICH; K FRONKOVA; L SLEGR
Journal:  Arch Kreislaufforsch       Date:  1958-09

5.  Vaso-motor factor in glaucoma.

Authors:  E G MACKIE
Journal:  Br J Ophthalmol       Date:  1958-01       Impact factor: 4.638

6.  [Comparative studies on arterial circulatory dynamics and kidney function in essential hypertension. II. Effects of pressure reduction by medication].

Authors:  H SCHWALB; W SCHIMMLER
Journal:  Klin Wochenschr       Date:  1955-10-15

7.  Hemodynamic effects of 1-hydrazinophthalazine in patients with arterial hypertension.

Authors:  G G ROWE; J H HUSTON; G M MAXWELL; A P CROSLEY; C W CRUMPTON
Journal:  J Clin Invest       Date:  1955-01       Impact factor: 14.808

8.  Studies on hydralazine; evidence for a peripheral site of action.

Authors:  A STUNKARD; L WERTHEIMER; W REDISCH
Journal:  J Clin Invest       Date:  1954-07       Impact factor: 14.808

9.  Cardiovascular and renal responses to the combination of hexamethonium and 1-hydrazinophthalazine (apresoline) in hypertensive subjects.

Authors:  D H STEIN; H H HECHT
Journal:  J Clin Invest       Date:  1955-06       Impact factor: 14.808

10.  Hemodynamic effects of 1-hydrazinophthalazine (apresoline) in human pregnancy: results of intravenous administration.

Authors:  N S ASSALI; S KAPLAN; S OIGHENSTEIN; R SUYEMOTO
Journal:  J Clin Invest       Date:  1953-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.